Copyright © 2004 by the Johns Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Estimating Long-term Trends in the Incidence and Prevalence of Opiate Use/Injecting Drug Use and the Number of Former Users: Back-Calculation Methods and Opiate Overdose Deaths
1 Health Protection Agency Statistics Unit, London, United Kingdom.
2 Medical Research Council Biostatistics Unit, Cambridge, United Kingdom.
3 Centre for Research on Drugs and Health Behaviour, Primary Care and Population Health Sciences, Imperial College London, London, United Kingdom.
4 BDS Statistics and Programming, GlaxoSmithKline, Greenford, London, United Kingdom.
The authors explored an age-specific back-calculation approach to estimating long-term trends in the incidence and prevalence of opiate use/injecting drug use (IDU) in England for 19682000. The incidence of opiate use/IDU was estimated by combining information on the observed opiate overdose deaths of persons aged 1544 years with knowledge on the distribution of the time between starting opiate use/IDU and death by overdose (incubation time distribution). The resulting incidence, together with the incubation time distribution, other drug-related mortality, and the general age-specific mortality rate, was then used to estimate the prevalence of current and former users. Provisional estimates suggested two major increases in incidence in the late 1970s and early 1990s, with models including information on age at death suggesting a recent decline since 1997 and that prevalence of opiate use/IDU increased substantially in the 1990s. Results were crucially dependent on assumptions about key parameters of the back-calculation framework. In theory, the approach is a valuable addition to the portfolio of indirect methods for estimating incidence and prevalence of dependent opiate use/IDU. In practice, its full potential will be realized only once better information on the process of stopping opiate use/IDU becomes available and more precise estimates of current and historical overdose mortality are obtained.
epidemiologic methods; incidence; overdose; prevalence; substance abuse, intravenous
Abbreviations: Abbreviations: EM, expectation-maximization; HIV, human immunodeficiency virus; IDU, injecting drug use.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M Hickman and D De Angelis Commentary Sex. Transm. Inf., April 1, 2008; 84(2): 115 - 116. [Full Text] [PDF] |
||||
![]() |
P Vickerman, M Hickman, and A Judd Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study Int. J. Epidemiol., April 1, 2007; 36(2): 396 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Morgan, C. Griffiths, and M. Hickman Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004 Int. J. Epidemiol., December 1, 2006; 35(6): 1579 - 1585. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Frisher, H. Heatlie, and M. Hickman Prevalence of problematic and injecting drug use for Drug Action Team areas in England J. Public Health Med., March 1, 2006; 28(1): 3 - 9. [Abstract] [Full Text] [PDF] |
||||


